DNA RNA and Cells
4 April 2013
Aastrom Biosciences Announces First Patients Enrolled in ixCELL-DCM Phase 2b Clinical Trial of Ixmyelocel-T26 March 2013
OncoSec Medical Updates Analysis of Interim Data for Phase II Study of ImmunoPulse in Metastatic Melanoma Patients13 March 2013
Ceregene And Alzheimer’s Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial4 March 2013
Sarepta’s Marburg Drug Shows High Survival Rates After Intramuscular Delivery in Non-Human Primates26 February 2013
Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation26 February 2013
United Therapeutics Moves Forward Towards a Phase I Study of Pluristem’s PLX-PAD Cells for Pulmonary Arterial Hypertension25 February 2013
Coronado Biosciences Announces Initiation of Investigator-Initiated Study Evaluating TSO in Psoriasis19 February 2013
Isis Initates Phase 2/3 Study Of ISIS-TTR Rx And Earns USD 7.5 Million Milestone Payment From GlaxoSmithKline15 February 2013
Gamida Cell’s NiCord Demonstrates Successful Engraftment in Patients with Hematological Malignancies in Phase I/II StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports